{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:33:15Z","timestamp":1792812795083,"version":"4.5.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"\n Importance<\/jats:title>\n Extant data on the performance of cardiovascular disease (CVD) risk score models in people living with HIV have not been synthesized.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To synthesize available data on the performance of the various CVD risk scores in people living with HIV.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n PubMed and Embase were searched from inception through January 31, 2021.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Selected studies (1) were chosen based on cohort design, (2) included adults with a diagnosis of HIV, (3) assessed CVD outcomes, and (4) had available data on a minimum of 1 CVD risk score.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n Relevant data related to study characteristics, CVD outcome, and risk prediction models were extracted in duplicate. Measures of calibration and discrimination are presented in tables and qualitatively summarized. Additionally, where possible, estimates of discrimination and calibration measures were combined and stratified by type of risk model.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Measures of calibration and discrimination.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Nine unique observational studies involving 75\u202f304 people (weighted average age, 42 years; 59\u202f490 male individuals [79%]) living with HIV were included. In the studies reporting these data, 86% were receiving antiretroviral therapy and had a weighted average CD4+\u2009count of 449 cells\/\u03bcL. Included in the study were current smokers (50%), patients with diabetes (5%), and patients with hypertension (25%). Ten risk prediction scores (6 in the general population and 4 in the HIV-specific population) were analyzed. Most risk scores had a moderate performance in discrimination (C statistic: 0.7-0.8), without a significant difference in performance between the risk scores of the general and HIV-specific populations. One of the HIV-specific risk models (Data Collection on Adverse Effects of Anti-HIV Drugs Cohort 2016) and 2 of the general population risk models (Framingham Risk Score [FRS] and Pooled Cohort Equation [PCE] 10 year) had the highest performance in discrimination. In general, models tended to underpredict CVD risk, except for FRS and PCE 10-year scores, which were better calibrated. There was substantial heterogeneity across the studies, with only a few studies contributing data for each risk score.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Results of this systematic review and meta-analysis suggest that general population and HIV-specific CVD risk models had comparable, moderate discrimination ability in people living with HIV, with a general tendency to underpredict risk. These results reinforce the current recommendations provided by the American College of Cardiology\/American Heart Association guidelines to consider HIV as a risk-enhancing factor when estimating CVD risk.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2022.4873","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T12:31:54Z","timestamp":1672230714000},"page":"139","source":"Crossref","is-referenced-by-count":60,"title":["Performance of Cardiovascular Risk Prediction Models Among People Living With HIV"],"prefix":"10.1001","volume":"8","author":[{"given":"Cullen","family":"Soares","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kwok","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent-Andrew","family":"Boucher","sequence":"additional","affiliation":[{"name":"27th Special Operations Medical Group, US Air Force, US Department of Defense, Cannon Air Force Base, Clovis, New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Haji","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin B.","family":"Echouffo-Tcheugui","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Longenecker","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald S.","family":"Bloomfield","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke Clinical Research Institute, Duke Global Health Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ross","sequence":"additional","affiliation":[{"name":"Office of Specialty Care Service, US Department of Veterans Affairs, Washington, DC"},{"name":"Infectious Disease Section, Washington DC Department of Veterans Affairs Medical Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jutkowtiz","sequence":"additional","affiliation":[{"name":"Center of Innovation in Long Term Services & Supports, Providence VA Medical Center, Providence, Rhode Island"},{"name":"Evidence Synthesis Program Center, Providence VA Health Care System, Providence, Rhode Island"},{"name":"Brown University School of Public Health, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Center of Innovation in Long Term Services & Supports, Providence VA Medical Center, Providence, Rhode Island"},{"name":"Brown University School of Public Health, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Rudolph","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brown University, Providence, Rhode Island"},{"name":"Center of Innovation in Long Term Services & Supports, Providence VA Medical Center, Providence, Rhode Island"},{"name":"Evidence Synthesis Program Center, Providence VA Health Care System, Providence, Rhode Island"},{"name":"Brown University School of Public Health, Brown University, Providence, Rhode Island"},{"name":"Department of Medicine, Providence VA Medical Center, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chih","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brown University, Providence, Rhode Island"},{"name":"Center of Innovation in Long Term Services & Supports, Providence VA Medical Center, Providence, Rhode Island"},{"name":"Brown University School of Public Health, Brown University, Providence, Rhode Island"},{"name":"Department of Medicine, Providence VA Medical Center, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebhat","family":"Erqou","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brown University, Providence, Rhode Island"},{"name":"Center of Innovation in Long Term Services & Supports, Providence VA Medical Center, Providence, Rhode Island"},{"name":"Evidence Synthesis Program Center, Providence VA Health Care System, Providence, Rhode Island"},{"name":"Department of Medicine, Providence VA Medical Center, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"21","key":"hoi220080r1","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.117.028975","article-title":"Cardiovascular risk prediction functions underestimate risk in HIV infection.","volume":"137","author":"Triant","year":"2018","journal-title":"Circulation"},{"issue":"11","key":"hoi220080r2","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1093\/cid\/ciw615","article-title":"Cardiovascular disease risk prediction in the HIV outpatient study.","volume":"63","author":"Thompson-Paul","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"hoi220080r3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamacardio.2016.4494","article-title":"Assessing and refining myocardial infarction risk estimation among patients with HIV: a study by the Centers for AIDS Research Network of Integrated Clinical Systems.","volume":"2","author":"Feinstein","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"12","key":"hoi220080r4","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1093\/jac\/dkw346","article-title":"Prediction of hard cardiovascular events in HIV patients.","volume":"71","author":"Raggi","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"hoi220080r5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/2047487315579291","article-title":"An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: the Data-CSollection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.","volume":"23","author":"Friis-M\u00f8ller","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"hoi220080r6","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"hoi220080r7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.exger.2004.03.004","article-title":"From Hayflick to Walford: the role of T-cell replicative senescence in human aging.","volume":"39","author":"Effros","year":"2004","journal-title":"Exp Gerontol"},{"issue":"4","key":"hoi220080r8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11904-021-00567-w","article-title":"Assessing cardiovascular risk in people living with HIV: current tools and limitations.","volume":"18","author":"Achhra","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"hoi220080r9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12879-017-2510-x","article-title":"Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study.","volume":"17","author":"De Socio","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"4","key":"hoi220080r10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/15284336.2016.1177266","article-title":"The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.","volume":"17","author":"Herrera","year":"2016","journal-title":"HIV Clin Trials"},{"issue":"5","key":"hoi220080r11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/QAI.0000000000002069","article-title":"Predictive performance of cardiovascular disease risk prediction algorithms in people living With HIV.","volume":"81","author":"van Zoest","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"hoi220080r12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/cid\/ciw564","article-title":"Baseline, time-updated, and cumulative HIV care metrics for predicting acute myocardial infarction and all-cause mortality.","volume":"63","author":"Salinas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"7","key":"hoi220080r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"hoi220080r14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"hoi220080r15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments.","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"hoi220080r16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/hiv.2006.7.issue-4","article-title":"The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D study.","volume":"7","author":"Law","year":"2006","journal-title":"HIV Med"},{"issue":"5","key":"hoi220080r17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/HJR.0b013e328336a150","article-title":"Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.","volume":"17","author":"Friis-M\u00f8ller","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"11","key":"hoi220080r18","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/ehjci\/jeaa168","article-title":"Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial.","volume":"21","author":"van der Aalst","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"hoi220080r19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/eurjpc\/zwab095","article-title":"Validation and comparison of 28 risk prediction models for coronary artery disease.","volume":"29","author":"Lenselink","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"hoi220080r20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/18734251MTAyoOTM05","article-title":"Cardiovascular risk assessment in people living with HIV: a systematic review and meta-analysis of real-life data.","volume":"18","author":"Grand","year":"2020","journal-title":"Curr HIV Res"},{"issue":"39","key":"hoi220080r21","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias.","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"hoi220080r22","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis.","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"hoi220080r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.23242","article-title":"Performance of the pooled cohort equations to estimate atherosclerotic cardiovascular disease risk by body mass index.","volume":"3","author":"Khera","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"19","key":"hoi220080r24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019291","article-title":"Coronary artery calcification and plaque characteristics in people living with HIV: a systematic review and meta-analysis.","volume":"10","author":"Soares","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"hoi220080r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14923","article-title":"Assessment of coronary artery disease with computed tomography angiography and inflammatory and immune activation biomarkers among adults with HIV eligible for primary cardiovascular prevention.","volume":"4","author":"Hoffmann","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"hoi220080r26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1001\/jamacardio.2016.5139","article-title":"Types of myocardial infarction among HIV-infected individuals in the US.","volume":"2","author":"Crane","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"1","key":"hoi220080r27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/QAI.0000000000002629","article-title":"HIV infection and incident heart failure: a meta-analysis of prospective studies.","volume":"87","author":"Chen","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"hoi220080r28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I(2) can be biased in small meta-analyses.","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"hoi220080r29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3318","article-title":"Comparisons of established risk prediction models for cardiovascular disease: systematic review.","volume":"344","author":"Siontis","year":"2012","journal-title":"BMJ"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2800100\/jamacardiology_soares_2022_oi_220080_1675366795.91783.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T11:05:47Z","timestamp":1675854347000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2800100"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2022.4873","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}